Navigation Links
SINOL USA, Inc. and Strategic Pharmaceutical Advisors, Inc. to Enter a Marketing Agreement for SINOL Nasal Spray

Strategic Pharmaceutical Advisors (SRxA) and Sinol USA, Inc. announced the signing of a Memorandum of Understanding signifying their intent to enter into a marketing agreement for SINOL Nasal Spray, an all natural, capsaicin-based product for fast relief from allergy and sinus congestion and headaches of all types.

Washington, DC, and Newtown, CT (PRWEB) July 1, 2008 -- Strategic Pharmaceutical Advisors (SRxA) and Sinol USA, Inc., announced today the signing of a Memorandum of Understanding signifying their intent to enter into a marketing agreement for SINOL Nasal Spray. Under the proposed terms of the agreement SRxA will lead the worldwide educational and information support of SINOL Nasal Spray to professional and consumer audiences.

Headquartered in Newtown Connecticut, Sinol USA Inc. is a healthcare company dedicated to the Development of products using all natural ingredients. Available without a prescription, SINOL Nasal Spray formulations use clean, old fashioned ingredients for fast relief from allergy and sinus congestion and headaches of all degrees and types.

SRxA is a health education and strategic planning firm with world-renowned physicians as its partners and advisors. As part of this agreement, SRxA will develop programming tailored to the education of professional and consumer audiences and deliver it in a variety of media appropriate for each target audiences. Strategic Pharmaceutical Advisors is headquartered in Washington, DC, with offices in London and Hong Kong.

In announcing this collaboration, Paul Carpenter, Chief Executive Officer of Sinol USA, Inc. noted, "SINOL Nasal Sprays have caught the attention of U.S. medical practitioners in a very short period of time. With this collaboration, we now look forward to expanding our US base and reaching an international physician audience through the proven expertise and global sphere of influence of Strategic Pharmaceutical Advisors."

Dr. Christos S. Efessiou, Strategic Pharmaceutical Advisors' Chief Executive Officer, commented "The option of providing the public with an all natural, non-prescription alternative for relief from allergy-related congestion and headaches, impressed our Team enough to seek an active partnership in SINOL. My colleagues and I are excited at the possibilities that this partnership will offer to healthcare professionals and to allergy and headache sufferers."

Sinol USA is presently working with Strategic BioSciences, a SRxA affiliate, in a pioneering new product reformulation agreement which is expected to offer significant advantages to SINOL users. The two companies expect to announce this agreement in the near future.

For more information please visit: and

# # #

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
2. Honour Healthcare and River Logic Deliver Comprehensive Integrated Business Planning Solution Through Strategic Alliance
3. American Well and Microsoft Enter Into a Strategic Collaboration to Bring Healthcare to Peoples Homes
4. StayWell Custom Communications Announces Strategic Alliance With HealthMedia
5. TetraQ and Q-Pharm form strategic alliance
6. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
7. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
8. Nonin(R) Medical Announces Strategic Relationship With Microsoft and its Microsoft HealthVault Platform
9. Xceed Molecular Licenses Signature from Moffitt Cancer Center and Adds Moffitt to Strategic Collaborator Program
10. Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics
11. Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry
Post Your Comments:
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... ... 2017 , ... On Saturday, October 21, the Health & Wellness Center at ... raise money for the American Heart Association Heart Walk. Teams of up to 10 ... to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... ...
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
Breaking Medicine Technology: